An expanding portfolio of next generation sequencing (NGS) panels and library preparation products for the accurate detection of genetic variants.
A broad range of array products for cytogenetics, rare disease, cancer and reproductive health research.
31 May 2017
OGT to be acquired by Sysmex Corporation
OGT to be acquired by Sysmex Corporation, a leading provider of haematology and in vitro diagnostics products
25 April 2017
OGT’s expanded NGS cancer panels enable sequencing of difficult genes